These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23416531)

  • 1. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.
    Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG
    J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis by chemically modified coagulation factor Xa.
    Pryzdial EL; Meixner SC; Talbot K; Eltringham-Smith LJ; Baylis JR; Lee FM; Kastrup CJ; Sheffield WP
    J Thromb Haemost; 2016 Sep; 14(9):1844-54. PubMed ID: 27359348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What drives "fibrinolysis"?
    Medcalf RL
    Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoproteolysis or plasmin-mediated cleavage of factor Xaalpha exposes a plasminogen binding site and inhibits coagulation.
    Pryzdial EL; Kessler GE
    J Biol Chem; 1996 Jul; 271(28):16614-20. PubMed ID: 8663221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor.
    Pryzdial EL; Lavigne N; Dupuis N; Kessler GE
    J Biol Chem; 1999 Mar; 274(13):8500-5. PubMed ID: 10085082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
    Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
    Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity.
    Urano T; Ihara H; Suzuki Y; Takada Y; Takada A
    Semin Thromb Hemost; 2000; 26(1):39-42. PubMed ID: 10805280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
    Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
    Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
    Foley JH; Cook PF; Nesheim ME
    J Biol Chem; 2011 Jun; 286(22):19280-6. PubMed ID: 21467042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.